Skip to main content
SpringerLink
Log in

Regenerative Therapies for Chronic Intradiscal Pain

  • Chapter
  • First Online:
Deer's Treatment of Pain

  • 168 Accesses

Abstract

Intervertebral disc degeneration involves a complex interaction of various processes including cell loss, inflammation, and matrix degradation. Many patients suffer relapsing and chronic back pain despite conservative and interventional treatment. Procedures including steroid injection, electrothermal therapy, and surgery have been met with challenges including lack of robust or long-term efficacy. The immunomodulatory and trophic effects of regenerative therapies have shown significant promise and attracted considerable interest from researchers, clinicians, and patients. Intradiscal injection of mesenchymal stem cell products and platelet-rich plasma is being studied increasingly by pain physicians as a novel therapy for the treatment of discogenic pain. Published studies in preclinical and human models demonstrate encouraging results, but well-powered, high-quality studies are needed to properly evaluate the safety and efficacy of such treatments. Regenerative therapies with bone marrow aspirate concentrate and platelet-rich plasma are offered in point-of-care settings. Treatments involving more sophisticated mesenchymal stem cells prepared with culture expansion or genetic modification are currently offered only in clinical trial settings with FDA approval.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Recommended Reading

  1. DePalma MJ, Ketchum JM, Saullo T. What is the source of chronic low back pain and does age play a role? Pain Med. 2011;12(2):224–33.

    Article  PubMed  Google Scholar 

  2. Manchikanti L, Singh V, Falco FJ, Benyamin RM, Hirsch JA. Epidemiology of low back pain in adults. Neuromodulation. 2014;17(Suppl 2):3–10.

    Article  PubMed  Google Scholar 

  3. Billis E, Koutsojannis C, Matzaroglou C, et al. Association of low back pain on physical, sociodemographic and lifestyle factors across a general population sample within Greece. J Back Musculoskelet Rehabil. 2017;30(2):279–90.

    Article  CAS  PubMed  Google Scholar 

  4. Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.

    Article  PubMed  Google Scholar 

  5. Teraguchi M, Yoshimura N, Hashizume H, et al. Progression, incidence, and risk factors for intervertebral disc degeneration in a longitudinal population-based cohort: the Wakayama spine study. Osteoarthr Cartil. 2017;25(7):1122–31.

    Article  CAS  Google Scholar 

  6. Paajanen H, Erkintalo M, Kuusela T, Dahlstrom S, Kormano M. Magnetic resonance study of disc degeneration in young low-back pain patients. Spine. 1989;14(9):982–5.

    Article  CAS  PubMed  Google Scholar 

  7. Zheng C-J, Chen J. Disc degeneration implies low back pain. Theor Biol Med Model. 2015;12(1):24.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.

    Article  PubMed Central  Google Scholar 

  9. Manchikanti L, Pampati V, Hirsch JA. Utilization of interventional techniques in managing chronic pain in medicare population from 2000 to 2014: an analysis of patterns of utilization. Pain Physician. 2016;19(4):E531–46.

    PubMed  Google Scholar 

  10. Farshad-Amacker NA, Hughes A, Herzog RJ, Seifert B, Farshad M. The intervertebral disc, the endplates and the vertebral bone marrow as a unit in the process of degeneration. Eur Radiol. 2017;27(6):2507–20.

    Article  PubMed  Google Scholar 

  11. Moore RJ. The vertebral endplate: disc degeneration, disc regeneration. Eur Spine J. 2006;15(Suppl 3):S333–7.

    Article  PubMed  Google Scholar 

  12. Taylor JR. Growth of human intervertebral discs and vertebral bodies. J Anat. 1975;120(Pt 1):49–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Wang F, Cai F, Shi R, Wang XH, Wu XT. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthr Cartil. 2016;24(3):398–408.

    Article  CAS  Google Scholar 

  14. Freemont AJ. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford). 2009;48(1):5–10.

    Article  CAS  Google Scholar 

  15. Trout JJ, Buckwalter JA, Moore KC. Ultrastructure of the human intervertebral disc: II. Cells of the nucleus pulposus. Anat Rec. 1982;204(4):307–14.

    Article  CAS  PubMed  Google Scholar 

  16. Johnson WE, Caterson B, Eisenstein SM, Hynds DL, Snow DM, Roberts S. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 2002;46(10):2658–64.

    Article  CAS  PubMed  Google Scholar 

  17. Johnson WE, Caterson B, Eisenstein SM, Roberts S. Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine. 2005;30(10):1139–47.

    Article  PubMed  Google Scholar 

  18. Wang D, Hu Z, Hao J, et al. SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway. Age (Dordr). 2013;35(5):1741–53.

    Article  CAS  Google Scholar 

  19. Wang J, Markova D, Anderson DG, Zheng Z, Shapiro IM, Risbud MV. TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem. 2011;286(46):39738–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tian Y, Yuan W, Fujita N, et al. Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-kappaB. Am J Pathol. 2013;182(6):2310–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther. 2009;11(4):R126.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Igarashi T, Kikuchi S, Shubayev V, Myers RR. 2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine. 2000;25(23):2975–80.

    Article  CAS  PubMed  Google Scholar 

  23. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS. mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine. 2002;27(9):911–7.

    Article  PubMed  Google Scholar 

  24. O'Donnell JL, O'Donnell AL. Prostaglandin E2 content in herniated lumbar disc disease. Spine. 1996;21(14):1653–5.. discussion 1655-1656

    Article  CAS  PubMed  Google Scholar 

  25. Shamji MF, Setton LA, Jarvis W, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62(7):1974–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Abe Y, Akeda K, An HS, et al. Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine. 2007;32(6):635–42.

    Article  PubMed  Google Scholar 

  27. Peng B, Wu W, Hou S, Li P, Zhang C, Yang Y. The pathogenesis of discogenic low back pain. J Bone Joint Surg. 2005;87(1):62–7.

    Article  CAS  Google Scholar 

  28. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45:e54.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Doorn J, Moll G, Le Blanc K, van Blitterswijk C, de Boer J. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev. 2012;18(2):101–15.

    Article  CAS  PubMed  Google Scholar 

  30. Strassburg S, Hodson NW, Hill PI, Richardson SM, Hoyland JA. Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. PLoS One. 2012;7(3):e33739.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Niu CC, Yuan LJ, Lin SS, Chen LH, Chen WJ. Mesenchymal stem cell and nucleus pulposus cell coculture modulates cell profile. Clin Orthop Relat Res. 2009;467(12):3263–72.

    Article  PubMed  Google Scholar 

  32. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.

    Article  CAS  PubMed  Google Scholar 

  33. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016;2016:6940283.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–48.

    Article  PubMed  Google Scholar 

  35. Simon J, McAuliffe M, Shamim F, Vuong N, Tahaei A. Discogenic low back pain. Phys Med Rehabil Clin N Am. 2014;25(2):305–17.

    Article  PubMed  Google Scholar 

  36. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine. 1995;20(17):1878–83.

    Article  CAS  PubMed  Google Scholar 

  37. Press J, Liem B, Walega D, Garfin S. Survey of inspection and palpation rates among spine providers: evaluation of physician performance of the physical examination for patients with low back pain. Spine. 2013;38(20):1779–84.

    Article  PubMed  Google Scholar 

  38. Manchikanti L, Abdi S, Atluri S, et al. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013;16(2 Suppl):S49–283.

    PubMed  Google Scholar 

  39. Burke J, Watson R, McCormack D, Fitzpatrick J, Stack J, Walsh M. MR endplate changes are associated with increased disc inflammatory mediator production. J Bone Joint Surg Br. 2003;85-B(SUPP II):164.

    Google Scholar 

  40. Maus TP, Aprill CN. Lumbar diskogenic pain, provocation diskography, and imaging correlates. Radiol Clin N Am. 2012;50(4):681–704.

    Article  PubMed  Google Scholar 

  41. Teichtahl AJ, Urquhart DM, Wang Y, et al. Lumbar disc degeneration is associated with modic change and high paraspinal fat content - a 3.0T magnetic resonance imaging study. BMC Musculoskelet Disord. 2016;17(1):439.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Jha SC, Higashino K, Sakai T, et al. Clinical significance of high-intensity zone for discogenic low back pain: a review. J Med Investig. 2016;63(1-2):1–7.

    Article  Google Scholar 

  43. Manchikanti L, Glaser SE, Wolfer L, Derby R, Cohen SP. Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician. 2009;12(3):541–59.

    PubMed  Google Scholar 

  44. Manchikanti L, Dunbar EE, Wargo BW, Shah RV, Derby R, Cohen SP. Systematic review of cervical discography as a diagnostic test for chronic spinal pain. Pain Physician. 2009;12(2):305–21.

    PubMed  Google Scholar 

  45. Shah RV, Everett CR, McKenzie-Brown AM, Sehgal N. Discography as a diagnostic test for spinal pain: a systematic and narrative review. Pain Physician. 2005;8(2):187–209.

    PubMed  Google Scholar 

  46. Manchikanti L, Benyamin RM, Singh V, et al. An update of the systematic appraisal of the accuracy and utility of lumbar discography in chronic low back pain. Pain Physician. 2013;16(2 Suppl):Se55–95.

    PubMed  Google Scholar 

  47. Cuellar JM, Stauff MP, Herzog RJ, Carrino JA, Baker GA, Carragee EJ. Does provocative discography cause clinically important injury to the lumbar intervertebral disc? a 10-year matched cohort study. Spine J. 2016;16(3):273–80.

    Article  PubMed  Google Scholar 

  48. Fraser RD, Osti OL, Vernon-Roberts B. Discitis after discography. J Bone Joint Surg. 1987;69(1):26–35.

    Article  CAS  Google Scholar 

  49. Sarig-Bahat H. Evidence for exercise therapy in mechanical neck disorders. Man Ther. 2003;8(1):10–20.

    Article  CAS  PubMed  Google Scholar 

  50. Madigan L, Vaccaro AR, Spector LR, Milam RA. Management of symptomatic lumbar degenerative disk disease. J Am Acad Orthop Surg. 2009;17(2):102–11.

    Article  PubMed  Google Scholar 

  51. Jandric S, Antic B. Low back pain and degenerative disc disease. Med Pregl. 2006;59(9-10):456–61.

    Article  PubMed  Google Scholar 

  52. Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:Cd012087.

    PubMed  Google Scholar 

  53. Inage K, Orita S, Yamauchi K, et al. Low-dose tramadol and non-steroidal anti-inflammatory drug combination therapy prevents the transition to chronic low back pain. Asian Spine J. 2016;10(4):685–9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg. 2017;124(1):44–51.

    Article  CAS  PubMed  Google Scholar 

  55. Park SH, Wackernah RC, Stimmel GL. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? J Pharm Pract. 2014;27(1):71–8.

    Article  PubMed  Google Scholar 

  56. Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015;350:g6380.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med. 2016;176(7):958–68.

    Article  PubMed  CAS  Google Scholar 

  58. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Lu Y, Guzman JZ, Purmessur D, et al. Nonoperative management of discogenic back pain: a systematic review. Spine. 2014;39(16):1314–24.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Helm Ii S, Deer TR, Manchikanti L, et al. Effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician. 2012;15(3):E279–304.

    PubMed  Google Scholar 

  61. Freeman BJ, Mehdian R. Intradiscal electrothermal therapy, percutaneous discectomy, and nucleoplasty: what is the current evidence? Curr Pain Headache Rep. 2008;12(1):14–21.

    Article  PubMed  Google Scholar 

  62. Macario A, Pergolizzi JV. Systematic literature review of spinal decompression via motorized traction for chronic discogenic low back pain. Pain Pract. 2006;6(3):171–8.

    Article  PubMed  Google Scholar 

  63. Nguyen C, Boutron I, Baron G, et al. Intradiscal glucocorticoid injection for patients with chronic low back pain associated with active discopathy: a randomized trial. Ann Intern Med. 2017;166(8):547–56.

    Article  PubMed  Google Scholar 

  64. Wullems JA, Halim W, van der Weegen W. Current evidence of percutaneous nucleoplasty for the cervical herniated disk: a systematic review. Pain Pract. 2014;14(6):559–69.

    Article  PubMed  Google Scholar 

  65. Manchikanti L, Falco FJ, Benyamin RM, et al. An update of the systematic assessment of mechanical lumbar disc decompression with nucleoplasty. Pain Physician. 2013;16(2 Suppl):Se25–54.

    PubMed  Google Scholar 

  66. Streitparth F, Disch AC. Interventions on the intervertebral discs. Indications, techniques and evidence levels. Radiologe. 2015;55(10):868–77.

    Article  CAS  PubMed  Google Scholar 

  67. Ong D, Chua NH, Vissers K. Percutaneous disc decompression for lumbar radicular pain: a review article. Pain Pract. 2016;16(1):111–26.

    Article  PubMed  Google Scholar 

  68. Freeman BJ. IDET: a critical appraisal of the evidence. Eur Spine J. 2006;15(Suppl 3):S448–57.

    Article  PubMed  Google Scholar 

  69. Helm S, Hayek SM, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician. 2009;12(1):207–32.

    PubMed  Google Scholar 

  70. Wang X, Wanyan P, Tian JH, Hu L. Meta-analysis of randomized trials comparing fusion surgery to non-surgical treatment for discogenic chronic low back pain. J Back Musculoskelet Rehabil. 2015;28(4):621–7.

    Article  PubMed  Google Scholar 

  71. Bydon M, De la Garza-Ramos R, Macki M, Baker A, Gokaslan AK, Bydon A. Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: a systematic review and meta-analysis of randomized controlled trials. J Spinal Disord Tech. 2014;27(5):297–304.

    Article  PubMed  Google Scholar 

  72. Jacobs WC, van der Gaag NA, Kruyt MC, et al. Total disc replacement for chronic discogenic low back pain: a Cochrane review. Spine. 2013;38(1):24–36.

    Article  PubMed  Google Scholar 

  73. Gautschi OP, Smoll NR, Joswig H, et al. Influence of age on pain intensity, functional impairment and health-related quality of life before and after surgery for lumbar degenerative disc disease. Clin Neurol Neurosurg. 2016;150:33–9.

    Article  PubMed  Google Scholar 

  74. Chakravarthy K, Chen Y, He C, Christo PJ. Stem cell therapy for chronic pain management: review of uses, advances, and adverse effects. Pain Physician. 2017;20(4):293–305.

    PubMed  Google Scholar 

  75. Sainoh T, Orita S, Miyagi M, et al. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthop Sci. 2016;21(1):2–6.

    Article  PubMed  Google Scholar 

  76. Sainoh T, Orita S, Miyagi M, et al. Single Intradiscal administration of the tumor necrosis factor-alpha inhibitor, Etanercept, for patients with discogenic low back pain. Pain Med. 2016;17(1):40–5.

    PubMed  Google Scholar 

  77. Song K, Gu T, Shuang F, et al. Adipose-derived stem cells improve the viability of nucleus pulposus cells in degenerated intervertebral discs. Mol Med Rep. 2015;12(3):4664–8.

    Article  CAS  PubMed  Google Scholar 

  78. Tsai TL, Wang B, Squire MW, Guo LW, Li WJ. Endothelial cells direct human mesenchymal stem cells for osteo- and chondro-lineage differentiation through endothelin-1 and AKT signaling. Stem Cell Res Ther. 2015;6:88.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  79. Cheng X, Zhang G, Zhang L, et al. Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med. 2017;22:261.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076–84.

    Article  CAS  PubMed  Google Scholar 

  81. Iyer SS, Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther. 2008;8(5):569–81.

    Article  CAS  PubMed  Google Scholar 

  82. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Miyamoto T, Muneta T, Tabuchi T, et al. Intradiscal transplantation of synovial mesenchymal stem cells prevents intervertebral disc degeneration through suppression of matrix metalloproteinase-related genes in nucleus pulposus cells in rabbits. Arthritis Res Ther. 2010;12(6):R206.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Crevensten G, Walsh AJ, Ananthakrishnan D, et al. Intervertebral disc cell therapy for regeneration: mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng. 2004;32(3):430–4.

    Article  PubMed  Google Scholar 

  85. Wuertz K, Godburn K, Iatridis JC. MSC response to pH levels found in degenerating intervertebral discs. Biochem Biophys Res Commun. 2009;379(4):824–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Wuertz K, Godburn K, Neidlinger-Wilke C, Urban J, Iatridis JC. Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc. Spine. 2008;33(17):1843–9.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Richardson SM, Walker RV, Parker S, et al. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells. 2006;24(3):707–16.

    Article  CAS  PubMed  Google Scholar 

  88. Watanabe T, Sakai D, Yamamoto Y, et al. Human nucleus pulposus cells significantly enhanced biological properties in a coculture system with direct cell-to-cell contact with autologous mesenchymal stem cells. J Orthop Res. 2010;28(5):623–30.

    CAS  PubMed  Google Scholar 

  89. Vadala G, Studer RK, Sowa G, et al. Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion. Spine. 2008;33(8):870–6.

    Article  PubMed  Google Scholar 

  90. Wang Z, Perez-Terzic CM, Smith J, et al. Efficacy of intervertebral disc regeneration with stem cells - a systematic review and meta-analysis of animal controlled trials. Gene. 2015;564(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  91. Gou S, Oxentenko SC, Eldrige JS, et al. Stem cell therapy for intervertebral disk regeneration. Am J Phys Med Rehabil. 2014;93(11 Suppl 3):S122–31.

    Article  PubMed  Google Scholar 

  92. Oehme D, Ghosh P, Goldschlager T, et al. Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate. J Neurosurg Spine. 2016;24(5):715–26.

    Article  PubMed  Google Scholar 

  93. Gullung GB, Woodall JW, Tucci MA, James J, Black DA, McGuire RA. Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J. 2011;2(4):13–8.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Obata S, Akeda K, Morimoto R, et al. Intradiscal injection of autologous platelet-rich plasma-serum induces the restoration of disc height in the rabbit anular needle puncture model: 12. Paper presented at: Spine Journal Meeting Abstracts 2010.

    Google Scholar 

  95. Obata S, Akeda K, Imanishi T, et al. Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther. 2012;14(6):R241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005;84(5):434–9.

    Article  CAS  PubMed  Google Scholar 

  97. Wan S, Borland S, Richardson SM, Merry CL, Saiani A, Gough JE. Self-assembling peptide hydrogel for intervertebral disc tissue engineering. Acta Biomater. 2016;46:29–40.

    Article  CAS  PubMed  Google Scholar 

  98. Li YY, Diao HJ, Chik TK, et al. Delivering mesenchymal stem cells in collagen microsphere carriers to rabbit degenerative disc: reduced risk of osteophyte formation. Tissue Eng Part A. 2014;20(9-10):1379–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Tong W, Lu Z, Qin L, et al. Cell therapy for the degenerating intervertebral disc. Transl Res. 2017;181:49–58.

    Article  PubMed  Google Scholar 

  100. Hunt CL, Her YF, Law LA, et al. Five generations of cell preparation: a translational framework for categorizing regenerative stem cell therapies. 2017;1(1).

    Google Scholar 

  101. Bowen JE. Technical issues in harvesting and concentrating stem cells (bone marrow and adipose). PM R. 2015;7(4 Suppl):S8–18.

    Article  PubMed  Google Scholar 

  102. Ho G, Leung VY, Cheung KM, Chan D. Effect of severity of intervertebral disc injury on mesenchymal stem cell-based regeneration. Connect Tissue Res. 2008;49(1):15–21.

    Article  PubMed  Google Scholar 

  103. Salem O, Wang HT, Alaseem AM, et al. Naproxen affects osteogenesis of human mesenchymal stem cells via regulation of Indian hedgehog signaling molecules. Arthritis Res Ther. 2014;16(4):R152.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Almaawi A, Wang HT, Ciobanu O, et al. Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells. Tissue Eng Part A. 2013;19(7-8):1039–46.

    Article  CAS  PubMed  Google Scholar 

  105. Du M, Pan W, Yang P, Ge S. [Effect of aspirin on cell biological activities in murine bone marrow stromal cells]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi =. Chin J Stomatol. 2016;51(3):160–5.

    Google Scholar 

  106. Wyles CC, Houdek MT, Wyles SP, Wagner ER, Behfar A, Sierra RJ. Differential cytotoxicity of corticosteroids on human mesenchymal stem cells. Clin Orthop Relat Res. 2015;473(3):1155–64.

    Article  PubMed  Google Scholar 

  107. Narouze S, Benzon HT, Provenzano DA, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2015;40(3):182–212.

    Article  CAS  PubMed  Google Scholar 

  108. Kitchel SH, Wang MY, Lauryssen CL. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery. 2005;57(4 Suppl):286–9; discussion 286-289.

    PubMed  Google Scholar 

  109. Hyer CF, Berlet GC, Bussewitz BW, Hankins T, Ziegler HL, Philbin TM. Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus. J Bone Joint Surg Am. 2013;95(14):1312–6.

    Article  PubMed  Google Scholar 

  110. Jones EA, Kinsey SE, English A, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002;46(12):3349–60.

    Article  PubMed  Google Scholar 

  111. Galotto M, Berisso G, Delfino L, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999;27(9):1460–6.

    Article  CAS  PubMed  Google Scholar 

  112. Liao HT, Chen CT. Osteogenic potential: comparison between bone marrow and adipose-derived mesenchymal stem cells. World J Stem Cells. 2014;6(3):288–95.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Guneta V, Tan NS, Chan SK, et al. Comparative study of adipose-derived stem cells and bone marrow-derived stem cells in similar microenvironmental conditions. Exp Cell Res. 2016;348(2):155–64.

    Article  CAS  PubMed  Google Scholar 

  114. Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641–8.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Wang SZ, Rui YF, Tan Q, Wang C. Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy. Arthritis Res Ther. 2013;15(5):220.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. Int Orthop. 2016;40(6):1321–8.

    Article  PubMed  Google Scholar 

  117. Hunt CL, Shen S, Nassr A, et al. Current understanding of safety and efficacy of stem cell therapy for discogenic pain—a systematic review of human studies. Tech Reg Anesth Pain Manag. 2015;19(1-2):32–7.

    Article  Google Scholar 

  118. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. Lumbar Intradiskal Platelet-Rich Plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM R. 2016;8(1):1–10; quiz 10

    Article  PubMed  Google Scholar 

  119. Akeda K, Ohishi K, Masuda K, et al. Intradiscal injection of autologous platelet-rich plasma releasate to treat discogenic low back pain: a preliminary clinical trial. Asian Spine J. 2017;11(3):380–9.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Orozco L, Soler R, Morera C, Alberca M, Sanchez A, Garcia-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92(7):822–8.

    Article  PubMed  Google Scholar 

  121. Pang X, Yang H, Peng B. Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain. Pain Physician. 2014;17(4):E525–30.

    PubMed  Google Scholar 

  122. Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. Int Orthop. 2016;40(1):135–40.

    Article  PubMed  Google Scholar 

  123. Comella K, Silbert R, Parlo M. Effects of the intradiscal implantation of stromal vascular fraction plus platelet rich plasma in patients with degenerative disc disease. J Transl Med. 2017;15(1):12.

    Article  PubMed  CAS  Google Scholar 

  124. Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal platelet-rich plasma injection for chronic discogenic low back pain: preliminary results from a prospective trial. Pain Med. 2016;17(6):1010–22.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA

    Christine L. Hunt

  2. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Luke A. Law

  3. Department of Physical Medicine and Rehabilitation, Division of Pain Medicine, Spine Center, Mayo Clinic, Rochester, MN, USA

    Wenchun Qu

Authors
  1. Christine L. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luke A. Law
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenchun Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wenchun Qu .

Editor information

Editors and Affiliations

  1. The Spine and Nerve Center of the Virginias, Charleston, WV, USA

    Timothy R. Deer

  2. Evolve Restorative Center, Santa Rosa, CA, USA

    Jason E. Pope

  3. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA

    Tim J. Lamer

  4. Pain Diagnostics and Interventional Care, Sewickley, PA, USA

    David Provenzano

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hunt, C.L., Law, L.A., Qu, W. (2019). Regenerative Therapies for Chronic Intradiscal Pain. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_90

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12281-2_90

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12280-5

  • Online ISBN: 978-3-030-12281-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation